Concepedia

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series

Michael Singer, Michael Jansen, Lyndon Tyler, Paul Woods, Faisal Ansari, Udit Jain, Joshua H. Singer, Darren Bell, Chelsey Krambeer

Clinical ophthalmology · 2016 · 26 citations · 26 references

DOIFull text

Open access

Abstract

In eyes with ME due to RVO, treatment with an anti-VEGF agent plus DEX implant provided a predictable duration of effect, as well as significant improvements in BCVA and CFT.

References

26

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

New England Journal of Medicine · 2015 · 1.5K citations · Full text

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion

Julia A. Haller, Francesco Bandello, Rubens Belfort et al. · Ophthalmology · 2010 · 1.1K citations

, , +7

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 982 citations · Full text

, , +4

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

Peter A. Campochiaro, David M. Brown, Carl C. Awh et al. · Ophthalmology · 2011 · 698 citations

, , +6

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion

Paul VanVeldhuisen, Neal L. Oden, Barbara A. Blodi et al. · Archives of Ophthalmology · 2009 · 673 citations · Full text